Accessibility Menu
Solventum logo

Solventum(NYSE) SOLV

Market Cap$15.08BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2024)+11%
5 YearN/A
1 Year+22%
1 Month+13%
Premium Feature
Moneyball Superscore
56/100
$88.69
+1.00%
+0.88Today
After hours$88.66-$0.03 (-0.04%)
Solventum last closing stock price
MetricPriceDate
Last closeUSD 88.612026-08-20
Solventum stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.49%USD 86.462026-08-13
1 month+12.74%USD 78.602026-07-21
3 month+15.33%USD 76.832026-05-22
Year to date+11.82%USD 79.242025-12-31
1 year+21.63%USD 72.852025-08-20
Since inception+10.76%USD 80.002024-03-26

Solventum Financials at a Glance

Market Cap

$15.08BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$8.31B

Net Income (TTM)

$1.43B

EPS (TTM)

$8.18

P/E Ratio

10.83

Dividend

$0.00

Beta (Volatility)

0.74 (Low)

Price

$88.69

Volume

2.432

Open

$87.09

Previous Close

$88.61

Daily Range

$87.03 - $89.44

52-Week Range

$62.38 - $90.00

Estimated Earnings Date

Nov 5, 2026

SOLV News

GettyImages-941740978-1201x801-d21b45d

The Largest Healthcare Companies by Market Cap in August 2026

Lyle DalyAug 6, 2026
Foolcom-Featured.png

Solventum (SOLV) Fiscal Q2 EPS Jumps 8%

Motley Fool Markets TeamAug 7, 2025
GettyImages-1493870747-600x400-bf06395.jpg

Solventum: Q4 EPS Beats, Cash Flow Dips

Motley Fool Markets TeamFeb 28, 2025

SOLV: Motley Fool Moneyball Superscore

56

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Solventum

Solventum Corporation makes tools and software for doctors and dentists. These products help medical professionals treat wounds and manage patient records. The company also creates supplies like stethoscopes and dental braces.

Beyond the Hospital Bed

  • MedSurg: Advanced wound care items, surgical tools, and stethoscopes; accounts for 62.1% of net sales in the second quarter of 2026.
  • Dental Solutions: Brackets, clear aligners, and filling materials; represents 17.9% of net sales in the second quarter of 2026.
  • Health Information Systems: Software for medical billing, coding, and computer-assisted physician documentation; provides 16.0% of net sales in the second quarter of 2026.
  • Water Business: Filtration products for drinking water retained after divesting the larger purification segment.

Shedding Weight for Growth

  • Sold the Purification and Filtration business to Thermo Fisher Scientific for $4 billion on Sept. 1, 2025.
  • Acquired Acera in December 2025 to bolster the MedSurg product lineup.
  • Announced an intent to separate the Health Information Systems business on Aug. 5, 2026.
  • Deployed a new U.S. enterprise resource planning (ERP) system, used to manage business data, in July 2026.

Global Science at Work

The company manages a global supply chain and benefits from over 70 years of innovation. It earns 40.6% of its sales from international markets outside the United States.

Second Quarter Scorecard

  • Total net sales reached $2.209 billion in the second quarter of 2026, up 2.2% year over year.
  • Operating income hit $181 million for the three-month period ended June 30, 2026, down 15.8% year over year.
  • Market capitalization was $13.4 billion in the second quarter of 2026, up 1.4% year over year.
  • Cash provided by operating activities was $38 million for the six-month period ended June 30, 2026.
  • Repurchased 4.8 million shares of common stock for $355 million in the first half of 2026.

Bottom Line

Solventum transitioned into an independent company after separating from 3M and is now streamlining its business through divestitures. It focuses on combining digital tools with physical medical products to serve global healthcare providers.

AI Generated • Aug 6, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

20,000

CEO

Bryan C. Hanson

Website

www.solventum.com

Headquarters

Eagan, MN 55121, US

SOLV Financials

Key Financial Metrics (TTM)

Gross Margin

54.69%

Operating Margin

24.99%

Net Income Margin

17.26%

Return on Equity

28.96%

Return on Capital

21.63%

Return on Assets

10.07%

Earnings Yield

9.23%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$15.08BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

170.22M

Volume

2.432

Avg. Volume

1.57M

Financials (TTM)

Gross Profit

$4.55B

Operating Income

$2.08B

EBITDA

$2.60B

Operating Cash Flow

$209.00M

Capital Expenditure

-$327.00M

Free Cash Flow

-$118.00M

Cash & ST Invst.

$403.00M

Total Debt

$5.29B

Solventum Performance Analysis

Solventum annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 8,130,000,000-0.5%
20232023-12-31USD 8,197,000,0000.8%
20242024-12-31USD 8,254,000,0000.7%
20252025-12-31USD 8,325,000,0000.9%
Solventum sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-3.0%
Q42025-12-31-4.7%
Q12026-03-310.5%
Q22026-06-3010.1%
Solventum annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 7.78-8.0%
20232023-12-31USD 7.790.2%
20242024-12-31USD 2.76-64.6%
20252025-12-31USD 8.88221.9%
Solventum sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-301315.7%
Q42025-12-31-94.9%
Q12026-03-31-81.1%
Q22026-06-30657.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$2.21B

+2.2%

Gross Profit

$1.29B

+9.4%

Gross Margin

58.22%

N/A

Market Cap

$15.08BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$732.78K

N/A

Employees

20,584

N/A

Net Income

$92.00M

+2.2%

EBITDA

$172.00M

-47.6%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$403.00M

-18.1%

Total Debt

$5.29B

-32.4%

Accounts Receivable

$1.43B

+14.1%

Inventory

$1.04B

+8.1%

Long Term Debt

$4.78B

-38.8%

Short Term Debt

$506.00M

N/A

Return on Assets

10.07%

N/A

Return on Invested Capital

19.63%

N/A

Free Cash Flow

$144.00M

+144.1%

Operating Cash Flow

$227.00M

+34.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RVTYRevvity, Inc.
$124.13+3.92%
ICLRICON Public Limited Company
$174.27+1.03%
EHCEncompass Health Corporation
$120.91-0.68%
ELANElanco Animal Health Incorporated
$23.56-3.84%

Trending Stocks

Symbol / CompanyPricePrice Chg
IBITiShares Bitcoin Trust
$41.20+0.06%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$46.25-0.02%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$122.21+0.01%
MSTRStrategy
$112.39+0.08%

Questions About SOLV

What is the current price of Solventum?

Solventum is trading at $88.61 per share.

What is the 52-week range for Solventum?

Over the past 52 weeks, Solventum has traded between $62.38 and $90.00.

How much debt does Solventum have?

As of the most recent reporting period, Solventum reported total debt of $5.29B.

How much cash does Solventum have on hand?

Solventum reported $403.00M in cash and cash equivalents in its most recent financial results.

What is Solventum’s dividend yield?

Solventum does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services